Patent Law Amendments May Boost Clinical Trials in UK

Drug Industry Daily
A A
New amendments to patent laws in the UK could create a more attractive place for innovator drug companies to conduct clinical trials for novel drugs, experts say.

To View This Article:

Login

Subscribe To Drug Industry Daily